Terms: = Cervical cancer AND FOXO1, Q12778, FOXO1A, 2308, ENSG00000150907, FKH1, FKHR AND Treatment
5 results:
1. miR-96 enhances the proliferation of cervical cancer cells by targeting foxo1.
Yang L; Liu L; Zhang X; Zhu Y; Li L; Wang B; Liu Y; Ren C
Pathol Res Pract; 2020 Apr; 216(4):152854. PubMed ID: 32057517
[TBL] [Abstract] [Full Text] [Related]
2. MicroRNA-9 enhances invasion and migration of cervical carcinomas by directly targeting foxo1.
Aishanjiang A; Rouzi N; Jiao Z; Wang L; Wusainahong K; Wumanjiang N; Musha M; Niyazi M
Eur Rev Med Pharmacol Sci; 2018 Apr; 22(8):2253-2260. PubMed ID: 29762826
[TBL] [Abstract] [Full Text] [Related]
3. Suppression of forkhead box Q1 by microRNA-506 represses the proliferation and epithelial-mesenchymal transition of cervical cancer cells.
Zhang M; Xu Q; Yan S; Li Z; Yan W; Jia X
Oncol Rep; 2016 May; 35(5):3106-14. PubMed ID: 26935526
[TBL] [Abstract] [Full Text] [Related]
4. A phthalide derivative isolated from endophytic fungi Pestalotiopsis photiniae induces G1 cell cycle arrest and apoptosis in human HeLa cells.
Chen C; Yang RL
Braz J Med Biol Res; 2013 Aug; 46(8):643-9. PubMed ID: 23903687
[TBL] [Abstract] [Full Text] [Related]
5. Epigallocatechin-3-gallate inhibits epidermal growth factor receptor signaling pathway. Evidence for direct inhibition of ERK1/2 and AKT kinases.
Sah JF; Balasubramanian S; Eckert RL; Rorke EA
J Biol Chem; 2004 Mar; 279(13):12755-62. PubMed ID: 14701854
[TBL] [Abstract] [Full Text] [Related]
